AVE

Avecho Biotechnology Limited

AU Healthcare Biotechnology

Latest week
10 Jul 2026
Close
0.022000
Fair value
0.005769
Next-week expectancy
Negative 39.86%
Sharemaestro

AVE Chart Pack

Avecho Biotechnology Limited

Exchange
ASX
Latest week
10 Jul 2026
Close
0.022000
Fair value
0.005769
Next-week expectancy
Negative 39.86%
Generated
16 Jul 2026 22:08
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, AVE rose 100.00%, moving from 0.01 to 0.02. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 130.67 and has improved across the 12-week window. Market Dynamics is 1.55 on the latest week. Next-week expectancy is negative at 39.86% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
0.02
12-Week Change
100.00%
Trend Signal
Active
Next-Week Expectancy
Negative 39.86%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
130.67
Market Dynamics
1.55

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
0.02
12-Week Change
100.00%
Trend Signal
Active
Next-Week Expectancy
Negative 39.86%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
130.67
Market Dynamics
1.55

Over the latest 12 completed weeks ending 2026-07-10, AVE rose 100.00%, moving from 0.01 to 0.02. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 130.67 and has improved across the 12-week window. Market Dynamics is 1.55 on the latest week. Next-week expectancy is negative at 39.86% based on similar historical setup states.

Industry Peers

Australia equities in Biotechnology

Stock Exchange Week Open High Low Close Change
VBS Vectus Biosystems Limited ASX 10 Jul 2026 0.12 0.16 0.12 0.16 33.33%
ACW Actinogen Medical Limited ASX 10 Jul 2026 0.04 0.04 0.04 0.04 22.22%
ILA Island Pharmaceuticals Limited ASX 10 Jul 2026 0.38 0.55 0.38 0.45 20.00%
IMC Immuron Limited ASX 10 Jul 2026 0.04 0.04 0.04 0.04 10.26%
MSB Mesoblast Limited ASX 10 Jul 2026 2.04 2.30 1.97 2.24 9.80%
ENP Entropy Neurodynamics Limited ASX 10 Jul 2026 0.03 0.04 0.03 0.04 9.38%
BOT Botanix Pharmaceuticals Limited ASX 10 Jul 2026 0.02 0.03 0.02 0.02 9.09%
CU6 Clarity Pharmaceuticals Ltd ASX 10 Jul 2026 2.21 2.65 2.20 2.41 9.05%
TTX Tetratherix Limited ASX 10 Jul 2026 5.86 6.74 5.80 6.25 6.66%
PTX Prescient Therapeutics Limited ASX 10 Jul 2026 0.07 0.08 0.07 0.07 2.86%
PYC PYC Therapeutics Limited ASX 10 Jul 2026 1.53 1.60 1.49 1.56 1.63%
CSL CSL Limited ASX 10 Jul 2026 121.85 126.98 120.75 122.89 0.85%
ANR Anatara Lifesciences Ltd ASX 10 Jul 2026 0.01 0.01 0.01 0.01 0.00%
BIT Biotron Limited ASX 10 Jul 2026 0.00 0.00 0.00 0.00 0.00%
BTC BTC Health Limited ASX 10 Jul 2026 0.06 0.06 0.06 0.06 0.00%
IXC Invex Therapeutics Ltd ASX 10 Jul 2026 0.11 0.11 0.11 0.11 0.00%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.